Autopsy report · NCT02258880

Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke

“study was stopped for business/administrative reasons and not for patient safety concerns”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Daiichi Sankyo

Sponsor type

Industry

Conditions

Stroke

Interventions

SUN13837; placebo

Participants

0

Sites

53

Countries

Canada, Israel, South Africa, United States

Trials that died the same way

• Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
  “Study stopped due to safety reasons.” (83% match in meaning)
• Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
  “The study was terminated due to administrative, non-safety related reasons.” (81% match in meaning)
• Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection
  “The study was stopped due to safety concerns” (81% match in meaning)
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
  “The study was terminated in the interest of patient safety.” (80% match in meaning)
• An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis
  “The study was stopped due to a non-clinical safety finding.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.